Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies – Cleave Therapeutics

Skip to content

Search for:

Home
About
Pipeline
Science
Newsroom
Contact

Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies

cleave-series-a-pr-final

admin2019-07-25T13:31:13-07:00October 11th, 2011|

Selected Archives

August 2019
July 2019
August 2016
July 2015
January 2015
September 2014
April 2013
November 2011
October 2011

© Copyright 2019 - | ALL RIGHTS RESERVED